This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clasper, S. Articles by Jackson, D. G. Search for Related Content PubMed PubMed Citation Articles by Clasper, S. Articles by Jackson, D. G.

A Novel Gene Expression Profile in Lymphatics Associated with Tumor Growth and Nodal Metastasis

¹ MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital; ² MRC Functional Genetics Unit, Department of Human Anatomy and Genetics, Oxford, United Kingdom; ³ Microbiology and Tumor Biology Centre, Karolinska Institute, Stockholm, Sweden; and ⁴ Max Planck Institute for Molecular Biomedicine, Münster, Germany

Requests for reprints: David G. Jackson, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom. Phone: 44-1865-222313; Fax: 44-1865-222502; E-mail: djackson{at}hammer.imm.ox.ac.uk.

Key Words: Lymphatic • endothelium • tumor • metastasis • array

Invasion of lymphatic vessels is a key step in the metastasis of primary tumors to draining lymph nodes. Although the process is enhanced by tumor lymphangiogenesis, it is unclear whether this is a consequence of increased lymphatic vessel number, altered lymphatic vessel properties, or both. Here we have addressed the question by comparing the RNA profiles of primary lymphatic endothelial cells (LEC) isolated from the vasculature of normal tissue and from highly metastatic T-241/vascular endothelial growth factor (VEGF)-C fibrosarcomas implanted in C57BL/6 mice. Our findings reveal significant differences in expression of some 792 genes (i.e., 2-fold up- or down-regulated, P 0.05) that code for a variety of proteins including components of endothelial junctions, subendothelial matrix, and vessel growth/patterning. The tumor LEC profile, validated by immunohistochemical staining, is distinct from that of normal, inflammatory cytokine, or mitogen-activated LEC, characterized by elevated expression of such functionally significant molecules as the tight junction regulatory protein endothelial specific adhesion molecule (ESAM), the transforming growth factor-β coreceptor Endoglin (CD105), the angiogenesis-associated leptin receptor, and the immunoinhibitory receptor CD200, and reduced expression of subendothelial matrix proteins including collagens, fibrillin, and biglycan. Moreover, we show similar induction of ESAM, Endoglin, and leptin receptor within tumor lymphatics in a series of human head and neck and colorectal carcinomas, and uncover a dramatic correlation between ESAM expression and nodal metastasis that identifies this marker as a possible prognostic indicator. These findings reveal a remarkable degree of phenotypic plasticity in cancer lymphatics and provide new insight into the processes of lymphatic invasion and lymph node metastasis. [Cancer Res 2008;68(18):7293–303]

This article has been cited by other articles:

				S. Hirakawa, M. Detmar, D. Kerjaschki, S. Nagamatsu, K. Matsuo, A. Tanemura, N. Kamata, K. Higashikawa, H. Okazaki, K. Kameda, et al. Nodal Lymphangiogenesis and Metastasis: Role of Tumor-Induced Lymphatic Vessel Activation in Extramammary Paget's Disease Am. J. Pathol., November 1, 2009; 175(5): 2235 - 2248. [Abstract] [Full Text] [PDF]

				F. Spinella, E. Garrafa, V. Di Castro, L. Rosano, M. R. Nicotra, A. Caruso, P. G. Natali, and A. Bagnato Endothelin-1 Stimulates Lymphatic Endothelial Cells and Lymphatic Vessels to Grow and Invade Cancer Res., March 15, 2009; 69(6): 2669 - 2676. [Abstract] [Full Text] [PDF]